Micrazym ®

Micrazym ®

Products
Micrazym ®
Micrazym ®

Information

Micrazym(R) is a pancreatin enzyme replacement medicine, used to treat digestive system conditions characterized by, or defined as Exocrine Pancreatic Insufficiency (EPI). Micrazym(R) consists of enteric coated pancreatine micropellets in capsules. Pancreatin in a blend of naturally derived enzymes (protease, lipase and amylase),which aid in digesting proteins, fats and carbohydrates respectively.
Main Categories
Pharmaceutical Products / ATC coding
All Categories
Alimentary Tract and MetabolismDigestives, incl. EnzymesPharmaceutical Products / ATC coding
Distribution areas
East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
AVVA Pharmaceuticals LtdAVVA Pharmaceuticals Ltd is a European based pharmaceutical company, aiming on becoming a reference innovation hub for the development of biological medicines and new small molecules, with ultimate goal on providing a meaningful and affordable healthcare. The company focuses on developing biosimilars and biological medicines in partnership with leading international research and scientific centers. Our portfolio includes a number of inventions that will replace current standards in the fields of infectious and metabolic diseases.

Log in

See all the content and easy-to-use features by logging in or registering!